Analyst firms · Morgan Stanley · CTLT
Morgan Stanley CTLT price target and rating history
Catalent Inc. (CTLT) · Health Care
Morgan Stanley rates Catalent Inc. (CTLT) Overweight with a $145 price target, as of its latest action on Feb 2, 2022. It has published 3 rating actions on CTLT since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Overweight
- Price target
- $145
- Median target, all firms
- Too few
- Actions on CTLT
- 3
Morgan Stanley price target on CTLT
Every Morgan Stanley rating on CTLT
- Feb 2, 2022
- Nov 3, 2021
- Aug 31, 2021
Questions about Morgan Stanley and CTLT
- What is Morgan Stanley's price target for CTLT?
- Morgan Stanley's latest stated price target for Catalent Inc. (CTLT) is $145, from its action on Feb 2, 2022.
- What is Morgan Stanley's rating on CTLT?
- Morgan Stanley rates CTLT Overweight, a bullish rating, as of Feb 2, 2022.
- When did Morgan Stanley last change its view on CTLT?
- On Feb 2, 2022, Morgan Stanley cuts its price target to $145 from $160, keeps Overweight.
More CTLT rating histories
All Morgan Stanley ratingsCTLT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.